Cerebral arterial angioplasty in a patient with Loeys-Dietz syndrome

Christopher P Kellner1, Eric S Sussman1, Christopher Donaldson1

  • 1Department of Neurosurgery, Columbia University, New York, New York, USA.

Insights

This case study highlights a pediatric Loeys-Dietz syndrome patient experiencing delayed aneurysm rupture and severe vasospasm after subarachnoid hemorrhage. Refractory vasospasm presented a critical treatment challenge, underscoring the complexity of managing vascular complications in LDS.

Area of Science:

  • Neurology
  • Cardiovascular Research
  • Genetics

Background:

  • Loeys-Dietz syndrome (LDS) is a rare genetic connective tissue disorder associated with a high risk of aortic and arterial aneurysms and dissections.
  • Subarachnoid hemorrhage (SAH) is a life-threatening condition often caused by ruptured intracranial aneurysms, requiring prompt diagnosis and management.

Observation:

  • A 14-year-old boy with LDS presented with SAH, initially without an identifiable aneurysm source.
  • Delayed neurological decline occurred on post-bleed day 6, with CT showing new SAH and angiography revealing a basilar tip aneurysm.
  • Severe proximal vasospasm developed on post-bleed day 9, refractory to medical and intra-arterial vasodilator treatments.

Findings:

  • Endovascular coil embolization was performed for the basilar tip aneurysm.
  • Despite initial improvement, the patient developed severe, refractory vasospasm unresponsive to multiple treatment modalities.
  • The case presented a critical decision point regarding high-risk cerebral angioplasty versus continued maximal medical management for vasospasm in a pediatric LDS patient.

Implications:

  • This case underscores the potential for delayed aneurysm formation or rupture in LDS patients following initial SAH.
  • Refractory vasospasm poses a significant management challenge in the context of LDS, necessitating consideration of aggressive interventional strategies.
  • Further research into the vascular manifestations and optimal treatment paradigms for pediatric LDS patients experiencing cerebrovascular events is warranted.

Related Concept Videos